Magle Chemoswed Holding Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Magle Chemoswed Holding hat ein Gesamteigenkapital von SEK161.4M und eine Gesamtverschuldung von SEK58.7M, wodurch sich der Verschuldungsgrad auf 36.3% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen SEK290.7M bzw. SEK129.3M. Magle Chemoswed Holding Das EBIT des Unternehmens beträgt SEK18.3M, so dass der Zinsdeckungsgrad 6.5 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von SEK6.0M.

Wichtige Informationen

36.3%

Verhältnis von Schulden zu Eigenkapital

SEK 58.65m

Verschuldung

Zinsdeckungsgrad	6.5x
Bargeld	SEK 6.01m
Eigenkapital	SEK 161.42m
Gesamtverbindlichkeiten	SEK 129.27m
Gesamtvermögen	SEK 290.69m

Jüngste Berichte zur Finanzlage

Magle Chemoswed Holding (STO:MAGLE) Has A Pretty Healthy Balance Sheet

Jun 19

Recent updates

Market Participants Recognise Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Earnings Pushing Shares 37% Higher

Jun 26

Magle Chemoswed Holding (STO:MAGLE) Has A Pretty Healthy Balance Sheet

Jun 19

Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality

Apr 26

Earnings Tell The Story For Magle Chemoswed Holding AB (publ) (STO:MAGLE) As Its Stock Soars 28%

Mar 29

Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Price In Tune With Earnings

Oct 05

Should You Be Impressed By Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) ROE?

Jan 22

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: MAGLEDie kurzfristigen Aktiva des Unternehmens (SEK82.9M) übersteigen seine kurzfristigen Passiva (SEK78.3M).

Langfristige Verbindlichkeiten: MAGLEDie kurzfristigen Vermögenswerte des Unternehmens (SEK82.9M) übersteigen seine langfristigen Verbindlichkeiten (SEK51.0M).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: MAGLEDie Nettoverschuldung im Verhältnis zum Eigenkapital (32.6%) wird als zufriedenstellend angesehen.

Schulden abbauen: MAGLEDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 9.4% auf 36.3% gestiegen.

Schuldendeckung: MAGLEDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (30.5%).

Zinsdeckung: MAGLEDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (6.5x Coverage) gut gedeckt.

Magle Chemoswed Holding Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Magle Chemoswed Holding (STO:MAGLE) Has A Pretty Healthy Balance Sheet

Recent updates

Investor sentiment improves as stock rises 16%

Market Participants Recognise Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Earnings Pushing Shares 37% Higher

Magle Chemoswed Holding (STO:MAGLE) Has A Pretty Healthy Balance Sheet

Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality

First quarter 2024 earnings released: EPS: kr0.27 (vs kr0.27 in 1Q 2023)

Earnings Tell The Story For Magle Chemoswed Holding AB (publ) (STO:MAGLE) As Its Stock Soars 28%

Magle Chemoswed Holding AB (publ) (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (publ) (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million.

Full year 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Financial data availability

Magle Chemoswed Holding AB (publ) to Report Q4, 2024 Results on Feb 26, 2025

No independent directors

New minor risk - Share price stability

Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Price In Tune With Earnings

Investor sentiment improves as stock rises 16%

Full year 2022 earnings released: EPS: kr0.87 (vs kr0.39 in FY 2021)

Magle Chemoswed Holding AB 's Proprietary Product Axxo® Woundgel Receives Regulatory Approval in Kuwait

Magle Group's Vascular Embolic Product Embocept® S Receives Regulatory Approval in Argentina

No independent directors

Magle Group Appoints New Chief Marketing and Innovation Officer

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Magle Chemoswed Holding AB Announces the Resignation of Julia Kamber Rouhi from the Board of Directors of Magle Chemoswed Holding

Magle Group Announces First Patients Enrolled in a Post-Market Study of Medical Device SmartPAN®

Magle Chemoswed Holding AB (publ) Announces Post Market Clinical Study for SmartPAN®

Magle Chemoswed Holding AB (publ) to Report Q4, 2022 Results on Feb 16, 2023

Investor sentiment deteriorated over the past week

No independent directors

Full year 2021 earnings released: EPS: kr0.39 (vs kr0.24 in FY 2020)

Magle Chemoswed Holding AB (publ), Annual General Meeting, May 17, 2022

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Magle Chemoswed Holding AB (publ) to Report Fiscal Year 2021 Results on Feb 25, 2022

Full year 2020 earnings released: EPS kr0.24

Should You Be Impressed By Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) ROE?

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: kr44.60

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Magle Chemoswed Holding AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 20 million.

New 90-day high: kr35.00

New 90-day high: kr34.60

Magle Chemoswed Holding AB (publ) to Report Fiscal Year 2020 Results on Apr 14, 2021

New 90-day high: kr33.50

New 90-day high: kr30.90

Magle Chemoswed Holding AB (Publ) Announces the Appointment of Joel Eklund as New Member of the Board

Magle Chemoswed Holding AB (publ) has completed an IPO in the amount of SEK 50 million.

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen